Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.

Plajer, Sabine M; Chin, Paul K L; Vella-Brincat, Jane W A; Buffery, Pamela J; Begg, Evan J

Plajer, Sabine M; Chin, Paul K L; Vella-Brincat, Jane W A; Buffery, Pamela J; Begg, Evan J.

Affiliation

Plajer SM; Department of Medicine/Clinical Pharmacology, Christchurch Hospital and University of Otago, Christchurch, New Zealand. S. M. Plajer is now with Apotek 1 Mediegarden, 4013, Stavanger, Norway.

Ther Drug Monit ; 37(1): 98-103, 2015 Feb.

Article in En | MEDLINE | ID: mdl-24943063

Subject(s)

Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/pharmacokinetics; Gentamicins/adverse effects; Gentamicins/pharmacokinetics; Kidney Diseases/chemically induced; Kidney Diseases/complications; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents/administration & dosage; Creatinine/blood; Databases, Factual; Drug Administration Schedule; Drug Monitoring; Endpoint Determination; Female; Gentamicins/administration & dosage; Humans; Kidney Diseases/metabolism; Kidney Function Tests; Male; Middle Aged; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gentamicins / Kidney Diseases / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ther Drug Monit Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google